article thumbnail

123 organizations come out in support of FIND Act aimed at strengthening diagnostic imaging pay

Radiology Business

Backers include societies representing radiologists and nuclear medicine professionals, device manufacturers, patient advocacy groups, and pharmaceutical companies.

article thumbnail

The Transformative Impact of Radiopharmaceuticals in Medical Imaging

Open Medscience

Radiopharmaceuticals, combining radioactive and pharmaceutical elements, enable precise diagnosis and treatment in nuclear medicine. The post The Transformative Impact of Radiopharmaceuticals in Medical Imaging appeared first on Open Medscience.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Evans named Gambhir Trailblazer Award recipient

AuntMinnie

Evans, PhD, has been named the 2024 recipient of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Sam Gambhir Trailblazer Award. He completed a postdoctoral fellowship in molecular imaging at Memorial Sloan Kettering Cancer Center. He will be honored at the SNMMI's annual meeting in Toronto.

article thumbnail

First Ever Investigational 18F-CD8 PET Radiopharmaceutical Aims to Predict and Monitor Early Response to Cancer Immunotherapies

Imaging Technology

The study will also then help identify early response to immunotherapies, using sequential whole-body imaging to monitor CD8 changes over time, enabling physicians to switch patients who are not responding to alternative treatment options sooner. For more information: www.gehealthcare.com References: Shankar L.

article thumbnail

GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)

Imaging Technology

is the only FDA approved FES PET imaging agent. Cerianna is indicated for use with PET imaging for the detection of ER+ lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer. GE HealthCare’s Cerianna , available in the U.S., J Nucl Med. 2011;52(10):1541-1549 / Currin, et al. J Natl Compr Canc Netw.

Clinic 65
article thumbnail

NorthStar Medical Radioisotopes Announces Promotion of Jason Vinyard, MBA, MHA, to Vice President, Business Development, Therapeutic Technologies

Imaging Technology

Earlier in his career, he held operational responsibilities for facility management of isotope production with Regional Nuclear Pharmaceuticals (now Cardinal Health). Mr. Vinyard, who has been with NorthStar since 2021, was previously Senior Director, Business Development, Therapeutic Technologies, for the Company. SPECT franchise.

article thumbnail

GE HealthCare Announces Agreement to Acquire MIM Software

Imaging Technology

GE HealthCare expects to leverage MIM Software’s imaging analytics and digital workflow capabilities across various care areas to accelerate innovation and differentiate its solutions for the benefit of patients and healthcare systems around the world.